DOCSLIB.ORG

Guidance on the Compilation of Safety Data Sheets

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Guidance on the Compilation of Safety Data Sheets GUIDANCE Guidance on the compilation of safety data sheets Version 4.0 December 2020 Guidance on the compilation of safety data sheets 2 Version 4.0 December 2020 LEGAL NOTICE This document aims to assist users in complying with their obligations under the REACH Regulation. However, users are reminded that the text of the REACH Regulation is the only authentic legal reference and that the information in this document does not constitute legal advice. Usage of the information remains under the sole responsibility of the user. The European Chemicals Agency does not accept any liability with regard to the use that may be made of the information contained in this document. Reference: ECHA-20-H-25-EN ISBN: 978-92-9481-787-7 Publ. date: December 2020 Cat. Number: ED-01-20-770-EN-N DOI: 10.2823/77155 Language: EN © European Chemicals Agency, 2020 If you have any questions or comments in relation to this document, please send them (quote the reference and issue date) using the information request form. The information request form can be accessed via the Contact ECHA page at: http://echa.europa.eu/contact European Chemicals Agency Mailing address: P.O. Box 400, FI-00121 Helsinki, Finland Visiting address: Telakkakatu 6, Helsinki, Finland Guidance on the compilation of safety data sheets Version 4.0 December 2020 3 Version Changes Date Version 1.0 First edition. September 2011 Version 1.1 Corrigendum covering the following: December 2011 (1) Footnote 25 on page 24 has been corrected by expanding it to include a full listing of hazard classes or categories under (b), (c), (d) as well as those under (a) already given. (2) In the discussion of M-factors for mixture components under 3.2 on page 51 a reference to preference for listing in 2.1 (which applies for substances) has been corrected to clarify that for mixtures M-factors for components should be indicated together with their classification information under 3.2. Version 1.2 Corrigendum of Spanish language version. April 2013 Version 2.0 Update of the guidance covering in particular the extension of December 2013 Appendix 2 of this guidance by transfer and update of information previously included in a separate guidance document (Part G of the Guidance for IR&CSA). The updated Appendix provides guidance on how to include exposure scenario information in an SDS and on how to extend an SDS by attaching the exposure scenario. Updated guidance is provided on the correlation between the exposure scenario and SDS sections. The update also covers the following issues: (1) Addition of a note in chapter 3.14 concerning the provision under Regulation No 649/2012 (PIC regulation) to provide an SDS in the language of the country or area of destination. (2) Update of chapter 3.22 by deleting information already covered by the updated Guidance for downstream users (version 2.0). (3) Update of chapter 3.23 to ensure consistency with the updated Guidance for downstream users (version 2.0). In particular one additional option for downstream users who need to forward information on mixtures has been added. (4) Update of table 2 in Appendix 1 to delete information on transition periods which have already expired and to add clarifying detail in improved format on the retained information. (5) Minor corrections to update hyperlinks and typographical errors. (6) Change of format to a new ECHA corporate identity. Version 2.1 Corrigendum to the English language version only. February 2014 Deletion of the final part of the sentence within brackets in the second paragraph of chapter 3.22. It now reads as follows: ”(i.e. those fulfilling the PBT/vPvB criteria or the criteria for any of the listed hazard classes in Article 14(4) of REACH as amended by Article 58 of CLP)”. Version 2.2 Corrigendum to the following language versions only: BG, DA, December 2014 DE, GR, ES, ET, FI, FR, HR,HU, LT, MT, NL, RO, SL, SV. Guidance on the compilation of safety data sheets 4 Version 4.0 December 2020 Replacement in chapters 4.2, 4.3 and 4.16 of the translated Hazards Class and Category Codes with the correct versions (i.e. English-based code text) as appear in Annex VI and VII of the CLP Regulation. Version 3.0 Update of the Guidance to take into account the end of the August 2015 transitional period for labelling mixtures according to the Dangerous Preparation Directive (DPD), the need to indicate the classification of their components according to the Dangerous Substances Directive (DSD) and reflect the full implementation of the CLP regulation. The update is limited to the following: (1) Deletion of the reference to obsolete version of Annex II (replaced by Annex II to Commission Regulation No 453/2010 and the Annex to Commission Regulation (EU) 2015/830); (2) Addition of references to Commission Regulation (EU) 2015/830 which applies form 1 June 2015; (3) Update of references to legal text as amended by Commission Regulation (EU) 2015/830; (4) Addition in chapter 1.1 of reference to tables 3.4.6, 3.6.2, 3.7.2, 3.8.3 and 3.9.4 of Annex I of CLP defining the conditions under which some mixtures which do not meet the criteria for classification as hazardous according to CLP also require an SDS to be prepared or be made available on request; (5) Addition in chapter 1.2 of a clarification of the scope of the updated guidance; (6) Addition of a new subchapter 1.3 with explanatory text on the transitional provisions in Commission Regulation (EU) 2015/830; (7) Deletion of original chapter 2 (and renumbering of chapter 3 and its subchapters) containing out of date information, no longer relevant for this document whose scope is now only to provide guidance on the compilation of SDSs according to the requirements in place from 1 June 2015; (8) Addition in chapter 2.14 of the clarification that the Hazard Class and Category Codes (as given in Annex VI and VII of the CLP Regulation) must not be translated when used in the SDS; (9) Addition in chapter 2.15 of clarification of the requirement to provide an SDS for non-hazardous mixtures meeting the requirements set out in Table 3.4.6 of Annex I of CLP; (10) Addition in chapter 2.16 of a clarification regarding the obligation to provide SDS on request for non-classified mixtures containing substances with EU-level workplaces exposure limits regardless of their concentration; (11) Addition in chapter 3.2 of the full reference to point 0.5 of Annex II of REACH according to Regulation (EU) 2015/830; (12) Deletion of Appendix 1 on the transitional period for the application of CLP labelling and corresponding SDS requirements; (13) Deletion of out of date information and minor linguistic corrections of the English language version. Guidance on the compilation of safety data sheets Version 4.0 December 2020 5 Version 3.1 Corrigendum to: November 2015 • Correct legal text of (EU) 2015/830 and correct highlighting of new legal text (BG, CS, DE, EL, ES, FI, FR, HR, HU, LT, LV, MT, NL, PL, PT, RO, SK, SL, SV); • Correct which text was highlighted in blue (ET); • Correct some punctuation and formatting (IT) • Delete the number of the MARPOL convention from example in chapter 3.14 (EN, BG, CS, EL, ES, FR, HR, HU, IT, LT, LV, MT, NL, PL, PT, SK, SL, SV). Version 4.0 Update of the guidance to take into account the revised Annex II applicable as of 1 January 2021. The update includes advice on the provisions regarding: • Nanoforms (various sections) • The unique formula identifier (UFI) (SDS Section 1.1) • Details of the supplier of the safety data sheet (SDS Section 1.3) • Endocrine disrupting properties (various sections) • The specific concentration limit, the M-factor and the acute toxicity estimate (SDS Sections 3.1 and 3.2) • An expansion of SDS Section 9: Physical and chemical properties, in line with the GHS • An update of SDS Section 14: Transport information • Application of the transition period (Art 2 of Regulation (EU) 2020/878) The update has also enabled minor corrections (e.g. updating of hyperlinks), and editing/removal of out-of-date advice (e.g. advice on the CLP transition period). Guidance on the compilation of safety data sheets 6 Version 4.0 December 2020 Table of Contents 1 General Introduction ............................................................................................ 8 1.1 The safety data sheet ........................................................................................................... 8 1.2 Aim of this guidance ........................................................................................................... 10 1.3 Transitional provision to implement the latest version of Annex II to REACH .............................. 10 1.4 Target audience of this guidance .......................................................................................... 11 1.5 Relation with CLP and GHS .................................................................................................. 11 2 Issues to consider when compiling an SDS ......................................................... 13 2.1 Definition of a safety data sheet (an SDS) ............................................................................. 13 2.2 Responsibility for the content of an SDS ............................................................................... 13 2.3 Claiming an SDS as confidential ........................................................................................... 14 2.4 Possibility of charging for supply of an SDS ........................................................................... 14 2.5 Who should compile an SDS ...............................................................................................
Load more

Recommended publications
  • Safety Introduction WARNING! This Test System Is Capable of Producing Potentially Lethal Instrument Safety Voltages
    Ultra System Overview Introduction Safety Introduction WARNING! This test system is capable of producing potentially lethal Instrument Safety voltages. All internal areas of the system must be accessed and Information serviced ONLY by trained and qualified personnel. Do not perform any servicing other than that contained in this documentation and This section describes the UltraFLEX read all safety information before attempting any operation or test system safety precautions. The maintenance procedures. test system generates and uses AC and DC high power and high voltage. The purpose of this section is to identify the hazards in the system to !!CAUTION! operation, service and applications personnel. Such personnel should Always wear safety glasses or safety goggles when working on the test system. read and understand this information before operating or servicing the system. !!CAUTION! Internal sheet metal portions of the test system may contain sharp edges, use care when working inside the test system. Page 1 of 3 Rev. 0736 Ultra System Overview Introduction General Safety Information Subsystem Safety Information The following general safety Table 1 identifies the safety concerns for the UltraFLEX subsystems. information is included in this section: Table 1 • General Safety Information • Safety Terms, Labels and Subsystem Safety Lockout/ Electrostatic Weight Liquid Safety Symbols Section Tagout Discharge Safety • Lockout/Tagout Computer Safety XX • ESD Damage Prevention and Control Measure Cooling XXX • Safety Certification DIB 24-Slot Interface XX • Material Handling Digital Signal Processor XX • Switches and Protective Barriers • Weight Safety Manipulator XX • Anti-Tip Fixture PDU XXX • Torque Specifications System Monitor and XXX Note Controller (SMC) Primary Support Board only.
    [Show full text]
  • GUIDELINE Safety Data Sheets and Pathogen Safety Data Sheets
    GUIDELINE UBC-RMS-OHS-GDL-14-001 Department of Risk Management Services Effective date: January 2, 2014 Review date: November 27, 2017 www.rms.ubc.ca Supersedes: Previous version Safety Data Sheets and Pathogen Safety Data Sheets 1. SCOPE This guideline provides directions for Regulatory and Best Practices for the use of Safety Data Sheets and Pathogen Safety Data Sheets (SDS and PSDS). It applies to all UBC employees working with chemicals and/or pathogens. 2. PURPOSE Safety Data Sheets (SDSs) and Pathogen Safety Data Sheets (PSDSs) are essential components in ensuring occupational health and safety within potentially hazardous environments. 3. BACKGROUND Under the new Workplace Hazardous Materials Information System (WHMIS 2015) the formerly known Material Safety Data Sheet (MSDS) became the Safety Data Sheet. The change is happening in several phases. After December 1, 2018, WHMIS 2015 will be the only system in use. Until then, employers are allowed in the workplace both MSDSs and SDSs. Important information regarding chemical, physiochemical, hazard/toxicity, required personal protective equipment, etc. are found on the SDS. In particular, WHMIS-related information will be found on the label of the agent of concern, with additional and more comprehensive information detailed in the SDS. Accordingly, the SDS for any new chemical, chemical mixture, or unknown agent should be fully reviewed prior to working with it. It is also important to note that suppliers are required to provide a SDS for each reagent (may be restricted to first time ordering). Similarly, Pathogen Safety Data Sheets (PSDSs) provide critical information regarding infectious materials, including the mode of transmission, disease symptoms, decontamination methods, PPE, and containment requirements.
    [Show full text]
  • INCEPTION IMPACT ASSESSMENT Revision of EU Legislation On
    Ref. Ares(2021)2969734 - 04/05/2021 INCEPTION IMPACT ASSESSMENT Inception Impact Assessments aim to inform citizens and stakeholders about the Commission's plans in order to allow them to provide feedback on the intended initiative and to participate effectively in future consultation activities. Citizens and stakeholders are in particular invited to provide views on the Commission's understanding of the problem and possible solutions and to make available any relevant information that they may have, including on possible impacts of the different options. TITLE OF THE INITIATIVE Revision of EU legislation on hazard classification, labelling and packaging of chemicals LEAD DG (RESPONSIBLE UNIT) ENV.B2, GROW.F2 LIKELY TYPE OF INITIATIVE Legislative initiative INDICATIVE PLANNING Q2 2022 ADDITIONAL INFORMATION https://ec.europa.eu/environment/strategy/chemicals-strategy_en The Inception Impact Assessment is provided for information purposes only. It does not prejudge the final decision of the Commission on whether this initiative will be pursued or on its final content. All elements of the initiative described by the Inception impact assessment, including its timing, are subject to change. A. Context, Problem definition and Subsidiarity Check Context The Commission’s European Green Deal1 sets a high ambition for zero pollution leading to a toxic-free environment. One of the first deliverables is the Chemicals Strategy for Sustainability: Towards a Toxic-free Environment2 adopted on 14 October 2020. The objectives of the strategy are to achieve a legitimate higher level of protection of citizens and of the environment against hazardous chemicals. It is also an opportunity to encourage innovation for the development of safe and sustainable alternatives and to promote the EU industry as a global frontrunner in the chemicals production and use.
    [Show full text]
  • Information Gathering for CLP Classification
    132 ANN IST SUPER SANITÀ 2011 | VOL. 47, NO. 2: 132-139 DOI: 10.4415/ANN_11_02_03 Information gathering for CLP classification Ida Marcello(a), Felice Giordano(b) and Francesca Marina Costamagna(a) 1272/2008 (a)Centro Nazionale Sostanze Chimiche, Istituto Superiore di Sanità, Rome, Italy ON (b) I Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Rome, Italy T A EGUL Summary. Regulation 1272/2008 includes provisions for two types of classification: harmonised classi- R fication and self-classification. The harmonised classification of substances is decided at Community level and a list of harmonised classifications is included in the Annex VI of the classification, labelling CLP and packaging Regulation (CLP). If a chemical substance is not included in the harmonised classifi- HE cation list it must be self-classified, based on available information, according to the requirements of T Annex I of the CLP Regulation. CLP appoints that the harmonised classification will be performed for carcinogenic, mutagenic or toxic to reproduction substances (CMR substances) and for respira- tory sensitisers category 1 and for other hazard classes on a case-by-case basis. The first step of clas- sification is the gathering of available and relevant information. This paper presents the procedure for gathering information and to obtain data. The data quality is also discussed. Key words: hazardous substances, European Union, information systems, classification, globally harmonized system. Riassunto (Raccolta di informazioni per la classificazione in accordo con il Regolamento CLP). Il Regolamento sulla classificazione, etichettatura e imballaggio di sostanze e miscele (CLP) considera due tipi di classifi- cazione: la classificazione armonizzata e l’autoclassificazione.
    [Show full text]
  • REACH Annex II SDS Changes Christine Lepisto SCHC Fall Meeting, 2020
    REACH Annex II SDS Changes Christine Lepisto SCHC Fall Meeting, 2020 AGENDA REACH Annex II SDS Changes The Basics: What, Why, When? Change drivers: UN GHS Revisions 6 and 7 CLP Regulation: Adaptations to Technical Progress CLP Regulation: NEW Annex VIII on Poison Centre Notification REACH Amendments: Registration of Nanoforms REACH and the European Union framework on endocrine disruptors REACH: Evolving trends in Substances of Very High Concern Accumulated effects on Section 3 of the SDS 1-Nov-20 © C. Lepisto, Chemical Safety Consulting, 2020 3 REACH Annex II SDS Changes WHAT, WHY, WHEN? 1-Nov-20 © C. Lepisto, Chemical Safety Consulting, 2020 4 THE BASICS What – Amendment to REACH • COMMISSION REGULATION (EU) 2020/878 of 18 June 2020 amending Annex II to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) 1-Nov-20 © C. Lepisto, Chemical Safety Consulting, 2020 5 THE BASICS Why – the Drivers • Revision of GHS: 12th ATP of CLP • The 12th ATP of CLP sets GHS 6th and 7th Revised edition requirements in effect by 17 October 2020. • Other changes related to CLP • Specific concentration limits, multiplying factors, acute toxicity estimates • Annex VIII Poison Centre Notification Unique Formula Identifier (UFI) • Related to REACH Annexes I, III and VI to XII • Nanoforms • European Union framework on endocrine disruptors • Emerging substances of very high concern (SVHCs) 1-Nov-20 © C. Lepisto, Chemical Safety Consulting, 2020 6 THE BASICS When – and “Really, when?” • SHALL APPLY FROM • DEROGATION: Safety data sheets not complying with the Annex to this Regulation may continue to be provided until… CEFIC:ECHA: 31 Dec Still 2022 NEWdiscussing,forReally, new and or IMPROVED! when? existing answer in SDSSDS guidance 1-Nov-20 © C.
    [Show full text]
  • SAFETY DATA SHEET Page 1 of 2 SECTION 1: PRODUCT and COMPANY IDENTIFICATION Product: SURE-STEP™ Part Number: 3567000 Manufacturer: W
    SAFETY DATA SHEET Page 1 of 2 SECTION 1: PRODUCT AND COMPANY IDENTIFICATION Product: SURE-STEP™ Part Number: 3567000 Manufacturer: W. R. MEADOWS, INC. Address: 300 Industrial Drive Hampshire, Illinois 60140 Telephone: (847) 214-2100 In case of emergency, dial (800) 424-9300 (CHEMTREC) Revision Date: 6/8/2021 Product Use: Additive for Non-Slip Surfaces SECTION 2: HAZARDS IDENTIFICATION/EXPOSURE LIMITS HMIS HAZARD STATEMENTS |Health| | 1 | WARNING! |Flammability| | 1 | Direct contact may cause mechanical irritation. |Reactivity| | 0 | PRECAUTIONARY STATEMENTS |Personal Protection| | | Avoid direct contact. SECTION 3: HAZARDS COMPONENTS % by SARA Vapor Pressure LEL Chemical Name: CAS Number Weight 313 (mm Hg@20°C) (@25°C) 1. Polypropylene Homopolymer 9003-07-0 90-100 No N/A N/A N/A = Not Applicable Under the reporting requirements of Section 313 of Title III of the Superfund Amendments and Reauthorization Act of 1966 (SARA) and 40 CFR Part 372, chemicals listed on the 313 List (40 CFR Part 373.65) are identified under the heading "SARA 313." SECTION 4: EMERGENCY AND FIRST AID PROCEDURES EYE CONTACT: Flush eyes with water for fifteen minutes. If symptoms persist, seek medical attention. SKIN CONTACT: Rinse affected areas with water. INHALATION: Remove from exposure source. Treat symptomatically. INGESTION: Not expected to be an exposure route. Non-toxic if ingested. MOST IMPORTANT SYMPTOMS/EFFECTS, ACUTE AND CHRONIC: See Section Eleven for Symptoms/Effects. SECTION 5: FIRE AND EXPLOSIVES HAZARDS FLASHPOINT: Not applicable; product is a solid. EXTINGUISHING MEDIA: Carbon dioxide, dry chemical, or fine water spray. CHEMICAL/COMBUSTION HAZARDS: Melts in proximity to fires resulting in slippery surfaces.
    [Show full text]
  • Etibor-68 Safety Data Sheet
    ETİBOR-68 SAFETY DATA SHEET Date of initial Issue : March 2007 Revision No : 08.2 Date of Revision : February 2019 ETİ MADEN İŞLETMELERİ GENEL MÜDÜRLÜĞÜ Ayvalı Mah. Halil Sezai Erkut Cad. Afra Sok. No: 1/A 06010 Keçiören/Ankara TÜRKİYE SECTION 1. Identification of the Substance and the Company 1.1. Product identifier Substance name : Disodium tetraborate, anhydrous Trade name : ETİBOR-68 (Anhydrous borax) Chemical name/synonyms: Anhydrous borax, dehydrated borax, disodium tetraborate anhydrous Index N° : 005-011-00-4 CAS N° : 1330-43-4 EC N° : 215-540-4 REACH Registration number: 01-2119490790-32-0002 1.2. Relevant identified uses of the substance and uses advised against Relevant identified uses The product is used in industrial manufacturing and formulation, among others in: - Metallurgical Fluxes - Glass - Fiberglass - Ceramics - Fertilizers - Flame retardants For area-specific use, see the exposure scenarios in the annex of this extended Safety Data Sheet (eSDS). Uses advised against Not applicable, there are no uses of Etibor-68 (Anhydrous borax) advised against. 1.3. Details of the supplier of the safety data sheet Importer Name : AB ETIPRODUCTS OY Address : Piispanportti 5, 02240 Espoo/FINLAND Phone No : + 358 9 819 444 40 Fax No : + 358 9 819 444 44 e-mail : [email protected] Manufacturer Name : ETİ MADEN İŞLETMELERİ GENEL MÜDÜRLÜĞÜ Address : Ayvalı Mah. Halil Sezai Erkut Cad. Afra Sok. No: 1/A 06010 Keçiören/Ankara TÜRKİYE Phone No : +90 312 294 20 00 Fax No : +90 312 232 71 84 1.4. Emergency phone number : +49 (0)6132-84463 (24-Hour-Number) GBK GmbH Page 2 of 14 SECTION 2.
    [Show full text]
  • Safety Data Sheet Per GHS Standard Format
    SDS Date: August, 2016 Safety Data Sheet Per GHS Standard Format SECTION 1: CHEMICAL PRODUCT AND COMPANY IDENTIFICATION Product Identifier Product Name: ABC® Asbestos Binding Compound No. 6421 White, No. 6422 Clear, No. 6423 Green Recommended Use of Product: Binder for Asbestos Fibers Information on the Supplier of the Safety Data Sheet Manufactured For: Emergency Telephone Numbers: Fiberlock Technologies, Inc. CHEM TEL: (U.S.): 1-800-255-3924 150 Dascomb Road (Outside the U.S.): 813-248-0585 Andover, MA 01810 P: 800-342-3755 F: 978-475-6205 SECTION 2: HAZARDS IDENTIFICATION Signal Word: WARNING GHS Label Statements Hazard Statements: Harmful if inhaled. Causes mild skin irritation. Causes serious eye irritation. GHS Classifications This product is considered hazardous by The 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200) Acute Toxicity-Inhalation (Vapors) Category 4 Acute Toxicity-Inhalation (Dust-mists) Category 2 Serious eye damage/eye irritation – Category 2 Skin sensitization – Category 1 Page 1 of 9 PRECAUTIONARY STATEMENTS Prevention: Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Use personal protection (eye protection, gloves) during application. When grinding/sanding dry films, wear respiratory protection. Response: If on skin, wash with plenty of soap and water. If in eyes, rinse cautiously for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. If inhaled, remove victim to fresh air. If exposed or concerned, get medical advice. Storage: Keep closures tight and containers upright to prevent leakage. KEEP FROM FREEZING. Product is non-combustible. Disposal: The coating and any contaminated diking material should be thoroughly air dried and collected into drums.
    [Show full text]
  • Material Safety Data Sheet for Cell Cultures (Biosafety Level 1) 1
    Material Safety Data Sheet: MSTO-211H / ID 300450 Material Safety Data Sheet for Cell Cultures (Biosafety Level 1) 1. Product Identification Name of cell line: MSTO-211H (CLS order no. 300450) Designation: Human Lung Mesothelioma cell line, permanent cell line 2. Company Identification CLS Cell Lines Service GmbH Dr. Eckener-Str. 8 D-69214 Eppelheim Germany Emergency phone number: +49 (0)6221 700799 3. Composition / Ingredients Unit: cryovial; frozen liquid Hazardous Ingredient(s) CAS no. Percentage EC no. Dimethyl Sulfoxide 67-68-5 10 200-664-3 Non-Hazardous Ingredient(s) Percentage DMEM, supplemented for freezing 60-80 FBS (Fetal Bovine Serum) 10-20 Cells 1 4. Hazards Identification Human source cell line Categorized as non-infectious and non-toxic 5. First Aid Measures Skin contact: Wash off immediately with plenty of water and soap. Eye contact: Flush eyes immediately with water for 10-15 minutes. Ingestion: If the material was swallowed, rinse the mouth with water. 6. Accidental Release Measures Use personal protective equipment Do not flush into surface water. Clean contaminated surface thoroughly. Autoclave before disposal into appropriated containers. CLS Cell Lines Service GmbH, Dr. Eckener-Straße 8, 69214 Eppelheim, Germany TEL: +49(0)6221 700799 FAX +49(0)6221 700717 [email protected] www.clsgmbh.de Page 1 of 2 Material Safety Data Sheet: MSTO-211H / ID 300450 7. Handling and storage Handling: Open only under a sterile workbench. Wear protective equipment. Handle as if containing infectious material. Storage: Keep the cryovial at -150°C (freezer) or at -196°C (liquid nitrogen vapour phase). 8. Personal Protection Hygienic measures Avoid the contact with skin, eyes and clothing.
    [Show full text]
  • The CLP Regulation: Origin, Scope and Evolution
    126 ANN IST SUPER SANITÀ 2011 | VOL. 47, NO. 2: 126-131 DOI: 10.4415/ANN_11_02_02 The CLP Regulation: origin, scope and evolution 1272/2008 ON I Paola Di Prospero Fanghella and Tiziana Catone T A Centro Nazionale Sostanze Chimiche, Istituto Superiore di Sanità, Rome, Italy EGUL R Summary. The CLP Regulation implements in the EU the UN Globally Harmonised System of Classification and Labelling applying the “building block approach”, that is taking on board the CLP hazard classes and categories which are close to the existing EU system in order to maintain the HE level of protection of human health and environment. This Regulation applies to all substances and T mixtures placed on the market and besides to classification, packaging and labelling it provides for the notification of the classification and labelling of substances to the Classification & Labelling Inventory established by ECHA. It came into force on 20 January 2009 but a transitional period is foreseen until 1 June 2015 for the full application. At the end of this period the “substance” and “preparation” Directives (respectively 67/548/EEC and 99/45/EC) will be repealed. Key words: GHS, CLP, classification and labelling, C&L Inventory, CLP helpdesk, CLP notification. Riassunto (Il Regolamento CLP: origine, scopo ed evoluzione). Il Regolamento CLP traspone nel- l’Unione Europea il sistema armonizzato globale delle Nazioni Unite applicando il criterio del building block approach che consente di adottare alcune classi e categorie di pericolo simili a quelle preesistenti nell’attuale sistema UE per mantenere il livello attuale di protezione della salute umana e dell’ambiente.
    [Show full text]
  • Safety Data Sheet
    US – OSHA SAFETY DATA SHEET Issue Date 04-Nov-2016 Revision Date 07-May-2020 Version 4 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Product identifier Product Name MenQuadfiTM Other means of identification Product Information Single-dose vial Supplied as a package of five vials Synonyms Meningococcal (Groups A, C, Y and W) Conjugate Vaccine Recommended use of the chemical and restrictions on use Recommended Use Active immunization to prevent invasive meningococcal disease caused by N meningitides serogroups A, C, Y and W. Uses advised against Not available. Details of the supplier of the safety data sheet Supplier Address 1 Sanofi Pasteur Discovery Drive Swiftwater, PA 18370 Emergency telephone number 24 Hour Emergency Phone Number 1-703-741-5970 / 1-800-424-9300 CCN # 2118 (CHEMTREC) 2. HAZARDS IDENTIFICATION Classification Health Hazards Not classified. Physical hazards Not classified. OSHA Regulatory Status This product is a vaccine that is safe for consumers when used according to the label directions. Potential hazards that may occur if product is not used according to the consumer label are as follows throughout the sheet. Label elements Emergency Overview Normal precautions common to safe manufacturing practice should be followed in handling and storage. Appearance Clear solution Physical state Liquid Odor Not available. Hazards not otherwise classified (HNOC) Not classified as a hazardous substance. _____________________________________________________________________________________________ Page
    [Show full text]
  • Interpretation and Implications of the European Commission Recommendation on the Definition of Nanomaterial
    Interpretation and implications of the European Commission Recommendation on the definition of nanomaterial RIVM Letter Report 601358001/2012 E.A.J. Bleeker et al. National Institute for Public Health and the Environment P.O. Box 1 | 3720 BA Bilthoven www.rivm.com Interpretation and implications of the European Commission Recommendation on the definition of nanomaterial RIVM Letter report 601358001/2012 E.A.J. Bleeker et al. RIVM Letter report 601358001 Colophon © RIVM 2012 Parts of this publication may be reproduced, provided acknowledgement is given to the 'National Institute for Public Health and the Environment', together with the title and year of publication. Eric A.J. Bleeker Flemming R. Cassee Robert E. Geertsma Wim H. de Jong Evelyn H. W. Heugens Marjorie Koers-Jacquemijns Dik van de Meent Agnes G. Oomen Jan Popma Anton G. Rietveld Susan W.P. Wijnhoven Contact: Eric A.J. Bleeker Expertise Centre for Substances [email protected] This investigation was commissioned by Interdepartmental Working Group on Risks of Nanotechnology (IWR) in the framework of Risks of Nanotechnology Knowledge and Information Centre (KIR nano). Page 2 of 43 RIVM Letter report 601358001 Abstract Interpretation and implications of the European Commission definition on nanomaterials In October 2011, the European Commission published the Recommendation on the Definition of Nanomaterial. RIVM considers this definition to be a good basis for further discussion that should focus on two aspects of the definition: the proposed size limits for nanoparticles (1 to 100 nanometres); and the requirement that at least 50 % of the number of particles should be in this size range.
    [Show full text]